P1038 (10045): A Phase I/II Safety, Tolerability, and Phamacokinetic Study of High-Dose Lopinavir/Ritonavir with or Without Saquinavir in HIV-Infected Pediatric Subjects Previously Treated with Protease Inhibitors

Study Status Study Restriction

Concluded

Not Applicable

Sites where the study is implemented:

CRS ID Site Name City Country

5011

Boston Medical Center Pediatric HIV Program

Boston

United States of America

5026

Mt. Sinai Medical Center

New York

United States of America

Study contacts:

No records returned.

CTS: IMPAACT Operations Center

Department of Health and Human ServicesNational Institutes of Health

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.